Association between ADA (AGE-D-DIMER-ALBUMIN) and Chest CT severity score in COVID-19 pneumonia

Author:

Maggio Enrico1,Bonito Giacomo1,Oliva Alessandra1,Mastroianni Claudio Maria1,Vezza Riccardo1,Pugliese Francesco1,Violi Francesco1,Ricci Paolo1,Loffredo Lorenzo1,Pignatelli Pasquale1

Affiliation:

1. Sapienza University of Rome

Abstract

Abstract

Purpose: This study aims to assess the association between ADA score with the severity of pneumonia, as evaluated by chest tomography using a severity score. Materials and Methods:In this observational study we enrolled 350 consecutive adult (≥18 years) patients with COVID-19-related severe acute pneumonia which needed hospitalization, consecutively admitted to non-intensive care unit (ICU) medical wards from March 2020 to March 2022. A standard high-resolution chest CT was performed in all cases with a multidetector CT scanner without intravenous contrast injection, except in case of suspicion of pulmonary embolism. ADA score and semi-quantitative CT Severity Score (CTSS) were calculated for all patients. A linear regression analysis and a correlation analysis regarding Severity Score were performed. Results: 350 COVID-19 patients (154 males (44%) and 196 females (56%)) were recruited. A linear correlation analysis showed that Severity Score correlates with ADA Score, P/F ratio, SpO2, Respiratory rate, pO2, GFR, Glycemia and CRP. Finally, a linear regression analysis confirmed the relation between Severity Score and ADA Score, GFR and CRP (p=0,003) (Predictors: ADA Score [IC 95% 0,041 - -0,402; p=0,017], GFR [IC 95% -0,095 - -0,001; p=0,045], CRP [IC 95% -0,077 - -0,001; p=0,044]). Conclusions: This study demonstrates a correlation between the ADA score and the severity of SARS-CoV-2 pneumonia. These findings suggest that the ADA score serves as an index not only capable of predicting thrombotic events but also associated with the severity of the radiological presentation. Future studies should assess the accuracy of the ADA score using non-SARS-CoV-2 pulmonary tomography scores.

Publisher

Springer Science and Business Media LLC

Reference36 articles.

1. Violi, F. et al. The ADA (Age-D-Dimer-Albumin) Score to Predict Thrombosis in SARS-CoV-2. Thromb Haemost. 2022;122(9):1567–1572. doi: 10.1055/a-1788-7592. Epub 2022 Mar 4.

2. Malgaj Vrečko, M., Aleš Rigler, A. & Večerić-Haler, Ž. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review. Int J Mol Sci. 2022;23(19):11307. doi: 10.3390/ijms231911307.

3. Thondapu, V. et al. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord. 2021;9(4):835–844.e4. doi: 10.1016/j.jvsv.2020.11.006. Epub 2020 Nov 12.

4. Jenner, W.J. & Gorog, D.A. Incidence of thrombotic complications in COVID-19: On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium. J Thromb Thrombolysis. 2021;52(4):999–1006. doi: 10.1007/s11239-021-02475-7. Epub 2021 May 28.

5. Abou-Ismail, M.Y., Diamond, A., Kapoor, S., Arafah, Y. & Nayak, L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020 Oct:194:101–115. doi: 10.1016/j.thromres.2020.06.029. Epub 2020 Jun 20.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3